Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma
- PMID: 38192631
- PMCID: PMC10772146
- DOI: 10.3389/fonc.2023.1281650
Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma
Abstract
As the second most common subtype of breast carcinoma, Invasive Lobular Carcinoma (ILC) microenvironment features have not been thoroughly explored. ILC has different histological subtypes and elucidating differences in their microenvironments could lead to a comprehensive development of cancer therapies. We designed a custom-made cancer associated fibroblast (CAFs) panel and used multiplex immunofluorescence to identify the differences in tumor microenvironment between Classic ILC and Pleomorphic ILC.
Materials and methods: Multiplex immunofluorescence were performed on formalin fixed paraffin embedded tissues using Opal-7 color kit. The antibodies used for phenotyping CAFs were Pan CK (AE1/AE3), CD45, A-SMA, FAP, S100, Thy-1 with optimized dilutions. The images were acquired and analyzed using Vectra 3.0 imaging system and InForm software respectively.
Results: We studied 19 different CAFs colocalized phenotypes in the tumor, stroma and overall tissue compartments between classic and pleomorphic ILC. Total A-SMA+, A-SMA+FAP+S100+ and A-SMA+S100+ CAFs demonstrated higher densities in classic ILC cases while FAP+S100+ and S-100+ CAFs were increased in the pleomorphic subtype samples.
Conclusion: Our study explores multiple CAFs phenotypes between classical and pleomorphic ILC. We showed that CAFs subset differ between Classic ILC and Pleomorphic ILC. A-SMA CAFs are more prevalent in the TME of classic ILCs whereas Pleomorphic ILCs are dominated by CAFs without A-SMA expression. This also iterates the importance of exploring this particular type of breast carcinoma in more detail, paving the way for meaningful translational research.
Keywords: Computational Pathology; ILC; Invasive Lobular Carcinoma; Multiplex immunofluorescence; cancer associate fibroblasts; tumor micro environment (TME).
Copyright © 2023 Batra, Ding, Pandurengan, Ibarguen, Rabassedas, Sahin, Wistuba, Parra and Raso.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10772146/bin/fonc-13-1281650-g006.gif)
Similar articles
-
Genomic assays for lobular breast carcinoma.J Clin Transl Res. 2022 Nov 10;8(6):523-531. eCollection 2022 Dec 29. J Clin Transl Res. 2022. PMID: 36451999 Free PMC article. Review.
-
Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.Breast Cancer Res Treat. 2022 Jul;194(2):279-295. doi: 10.1007/s10549-022-06627-y. Epub 2022 Jun 6. Breast Cancer Res Treat. 2022. PMID: 35666367
-
Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.Breast Cancer Res Treat. 2016 Aug;159(1):55-69. doi: 10.1007/s10549-016-3929-2. Epub 2016 Jul 28. Breast Cancer Res Treat. 2016. PMID: 27469595
-
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.Breast Cancer Res Treat. 2016 Jan;155(1):65-75. doi: 10.1007/s10549-015-3668-9. Epub 2015 Dec 29. Breast Cancer Res Treat. 2016. PMID: 26715212
-
Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.Ann Diagn Pathol. 2012 Jun;16(3):185-9. doi: 10.1016/j.anndiagpath.2011.10.001. Epub 2011 Dec 24. Ann Diagn Pathol. 2012. PMID: 22197540 Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous